Between 2021 and 2025, American General Life Insurance Company — now a Corebridge Financial subsidiary — expanded its direct CRE mortgage portfolio by $6.5B to $33.9B, growing through a cycle in which MetLife and Prudential each contracted.
American General Life Insurance Company carried a $27.4B direct lending book into 2021. Four years later it sits at $33.9B — now under the Corebridge Financial umbrella following AIG's 2022 IPO and full separation. That $6.5B gain positions it fourth by book size among nine peers with comparable disclosure windows, with three of those peers — MetLife, Prudential, and Jackson National — shrinking over the same period.
American General grew its direct CRE mortgage book 24% from 2021 to 2025, adding $6.5B in net exposure across the rate cycle. The trajectory is not linear: $27.4B to $31.2B through 2023, a pullback to $30.7B in 2024, then a surge to $33.9B in 2025 — the largest single-year dollar gain in the window. That pattern is consistent with a lender recalibrating underwriting standards mid-cycle and re-entering when competitor appetite contracted. Geographically, Florida absorbed $1.3B of growth (from $1.2B to $2.5B). Massachusetts added $0.9B. Connecticut and Illinois each shed $0.2B. The state-level shifts point to reallocation away from slower-absorption markets. The blended coupon held at 5% from 2022 through 2025 — flat across a 425bps Fed hiking cycle — anchoring yield below new-money spreads.
If the Fed holds at 4.25–4.50% through year-end, the 5% blended yield looks thin against new-money spreads, creating pressure to extend duration or accept tighter margins on 2025 originations. A 50bps cut flips that dynamic, making legacy 5% coupons a relative anchor. The more immediate risk is credit deterioration in the 2022–2023 vintage underwritten near peak valuations. Chicago Fed scenario analysis confirms LifeCo CRE portfolios face concentrated losses under widespread strategic default assumptions, with multifamily and office carrying the largest projected price declines. Florida insurance markets are stabilizing per 2025 regulatory filings, but commercial premiums remain elevated above pre-2022 norms, keeping NOI sensitivity on the $2.5B FL book a watch item.
At $33.9B, American General sits just above TIAA ($32.8B) and just below MetLife ($35.7B) in the nine-peer disclosure set. MetLife shrunk 14% over the same window. American General expanded 24%. That divergence in trajectory — not just book size — is the signal. A lender growing into a market that a comparable peer is exiting runs a different credit thesis. Corebridge's asset management relationships with Blackstone and BlackRock for portions of its investment portfolio add a layer of external influence on deployment that is not fully disclosed in public filings.
Three items in the next 90 days stress-test the 2025 deployment. First, Florida commercial insurance renewals: rates are stabilizing but remain elevated, and NOI sensitivity on $2.5B of FL exposure warrants monitoring against Q2 REIT earnings. Second, Massachusetts life-sciences and multifamily absorption: the $0.9B gain there should be tracked against Boston-market vacancy data. Third, Corebridge investment guideline disclosures: any shift in CRE concentration limits or changes to Blackstone/BlackRock mandates would cap further growth before the next origination window.
One American General signal, read three ways.
